Definitive Contract HHSO100201600030C

This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company and manufacturer. The contract, which has a period of performance through August 31, 2025, is for the development of medical countermeasures and pharmaceuticals, including filovirus treatments, a ketamine analgesic drug and auto injector system, and smallpox vaccines and diluents. The contract is not set aside. Emergent Product Development Gaithersburg has also received other recent federal contract, contract indefinite-delivery vehicle, grant, and subcontract awards from HHS and the Defense Health Agency.